Findings

What do systematic reviews say?

4 questions · 4 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 4 · 100%Moderate 0 · 0%High 0 · 0%

Pain at present McGill short form questionnaire ‐ Verbal rating scale (0‐5) · patients with pain management in rheumatoid arthritis

1 finding from 1 review

Neuromodulators for pain management in rheumatoid arthritis 2012 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Quality of sleep · patients with pain management in rheumatoid arthritis

1 finding from 1 review

Neuromodulators for pain management in rheumatoid arthritis 2012 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Withdrawals due to adverse events · patients with pain management in rheumatoid arthritis

Oromucosal cannabis (Sativex) showed no clear difference in withdrawal due to adverse events compared with placebo (low certainty).

1 finding from 1 review

Neuromodulators for pain management in rheumatoid arthritis 2012 · Cochrane Headline outcomes only
RR 0.13 [0.01, 2.39]
1 study · 58 participants
Low

Total adverse events · patients with pain management in rheumatoid arthritis

Oromucosal cannabis (Sativex) may leads to higher total adverse events compared with placebo (low certainty).

1 finding from 1 review

Neuromodulators for pain management in rheumatoid arthritis 2012 · Cochrane Headline outcomes only
RR 1.82 [1.1, 3]
1 study · 58 participants
Low